Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant phaeochromocytoma and hypercalcaemia

J A Bridgewater1, W A Ratcliffe, N J Bundred

  • 1Department of Clinical Pharmacology, Rayne Institute, University College Hospital, London, UK.

Postgraduate Medical Journal
|January 1, 1993
PubMed
Summary

Recurrent malignant pheochromocytoma can cause hypercalcemia. This condition was linked to parathyroid-related protein (PTHrp) found in both the tumor tissue and patient plasma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trial.

ESMO open·2026
Same author

Genomic correlates of response and resistance to the irreversible FGFR1-4 inhibitor futibatinib based on biopsy and circulating tumor DNA profiling.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Width of excision margins after breast conserving surgery for invasive breast cancer and distant recurrence and survival.

BMJ (Clinical research ed.)·2022
Same author

Erratum to "Impact of Oncotype DX Breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK" [Eur J Surg Oncol 43 (5) (2017) 931-937].

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017
Same author

Whither surgical quality assurance of breast cancer surgery (surgical margins and local recurrence) after paterson.

Breast cancer research and treatment·2017
Same author

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.

British journal of cancer·2017

Area of Science:

  • Endocrinology
  • Oncology
  • Nephrology

Background:

  • Malignant pheochromocytoma is a rare tumor with diverse clinical presentations.
  • Hypercalcemia is a serious complication that can arise from various endocrine and oncologic conditions.

Observation:

  • A patient presented with hypercalcemia attributed to recurrent malignant pheochromocytoma.
  • Diagnostic investigations revealed elevated parathyroid-related protein (PTHrp) levels in the plasma.

Findings:

  • Immunocytochemistry confirmed the presence of PTHrp within the tumor tissue.
  • The findings suggest a causal link between pheochromocytoma and hypercalcemia mediated by PTHrp.

Implications:

  • This case highlights a potential paraneoplastic syndrome associated with malignant pheochromocytoma.
  • Understanding the role of PTHrp in this context may inform diagnostic and therapeutic strategies for similar cases.
  • Further research is warranted to elucidate the mechanisms underlying PTHrp production in pheochromocytoma.

Related Experiment Videos